Emerging applications

Sleep apnea, fatty liver, and the heart

Tirzepatide’s reach now extends past diabetes and obesity into sleep apnea, fatty liver disease, cardiovascular outcomes, and diabetes prevention. The evidence here is a mix: one new approval, one striking early trial, and some genuinely open questions.

This unit sorts the emerging uses by how solid the evidence actually is, so the exciting results and the unproven ones stay clearly separated.